LORISSA LORENZO: Open Payments
NPI 1053970327 · MCKINLEYVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 33 payments from 11 companies in 2025. Trend: 2023 $1,129 · 2024 $787 · 2025 $784
Food & beverage: $774Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $281 |
| Arcutis Biotherapeutics, Inc. | 3 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Lilly USA, LLC | 3 | $76 |
| Janssen Biotech, Inc. | 4 | $65 |
| GENZYME CORPORATION | 1 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| Amgen Inc. | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18 |
Products named: SKYRIZI, Zoryve, DUPIXENT, COSENTYX, TREMFYA, TALTZ, ILUMYA, Otezla.
Industry payments across CA — which companies pay providers there.
